Chinese Journal of Dermatology ›› 2014, Vol. 47 ›› Issue (10): 738-739.

• Research reports • Previous Articles     Next Articles

Determination of plasma levels of interleukin-17 in patients with vitiligo

  

  • Received:2013-10-09 Revised:2013-11-06 Online:2014-10-15 Published:2014-10-01

Abstract: Miao Qing*, Yu Wei, Cheng Yanan, Jia Mingyan, Chang Aiwu. *Department of Dermatology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China Corresponding author: Miao Qing, Email: qing_miao@sina.com 【Abstract】 Objective To investigate the relationship between interleukin-17 (IL-17) and vitiligo. Methods Totally, 32 vitiligo patients and 30 healthy human controls were enrolled in this study. Blood samples were collected from all the subjects, and enzyme-linked immunosorbent assay (ELISA) was performed to determine the plasma levels of IL-17. The relationship of plasma IL-17 levels with disease stage, clinical course and lesion area was assessed. Results The plasma levels of IL-17 were significantly higher in the patients with progressive and stable vitiligo than in the healthy controls (both P < 0.05), and higher in the patients with progressive vitiligo than in those with stable vitiligo (P < 0.05). Moreover, the plasma levels of IL-17 were positively correlated with the area of vitiligo lesions (r = 0.456, P < 0.05), but unrelated to the clinical course of vitiligo (r = 0.239, P > 0.05). Conclusion IL-17 may play a certain role in the occurrence and development of vitiligo.

Key words: Vitiligo, Interleukin-17, Immunity

share this article